Table 3.
n | Improved | Same | Worsened | |
---|---|---|---|---|
Baseline to Biopsy 2 | 532 | 30% | 43% | 27% |
IFN treated | 261 | 31% | 40% | 29% |
Control | 271 | 30% | 44% | 26% |
Month 24 to Biopsy 3 | 531 | 26% | 41% | 33% |
IFN treated | 261 | 28% | 40% | 32% |
Control | 270 | 24% | 42% | 34% |
Baseline to Biopsy 3 | 533 | 32% | 34% | 34% |
IFN treated | 262 | 33% | 34% | 33% |
Control | 271 | 31% | 34% | 35% |